April 2015 Issue of The Medicine Maker

Celebrating medicine makers of all stripes in our Top 100, we present The Medicine Maker Power List 2015!

By eliminating protein A, researchers aim to deliver continuous processing at a fraction of the cost of conventional techniques.

It’s the timeless story: Teva wants Mylan, Mylan wants Perrigo, and Perrigo wants none of it

What impact will genetic changes have on new medicines currently in development?

But can pharma manufacturers do more to help prevent medication errors?

By mimicking natural evolution of enzymes, researchers are creating biocatalysts for reactions unheard of in nature.

Using tiny imperfections in the printing process to track individual products through the supply chain

Will bacteriophages be the savior of the human race in the post-antibiotic era or is it just pie in the sky?

To make way for more flexible approved analytical methods in pharma, we need a better understanding of the underlying scientific principles.

To launch a new company, you’ll need great science…and great perseverance.

When it comes to IP, large companies regularly trample over the rights of smaller firms.

Over 70 percent of pharma leaders admit their business relies heavily on fading revenue streams.

Sitting Down With... Dirk Sauer, Novartis’ Global Head, Development Franchise Ophthalmics.

We talk to Jasna Peter-Katalinic – a pioneer of the field - about her life in glycan analysis.

Analytical QbD (AQbD) promises to extend the rigor and benefits of QbD into the area of analytical method development.

This paper considers wet and dry granulation processes and the use of real-time particle size measurements in their optimization, focusing on the application of real-time laser diffraction and spatial filter velocimetry measurements.

Nasal spray products are increasingly valued for delivering systemic as well as locally-acting therapies, most notably hormone and migraine treatments

In this white paper we examine the deformulation workflow, demonstrating the value of the technique of Morphologically Directed Raman Spectroscopy (MDRS) within this context.

Progress is too often hampered by our inability to gather the information needed to make advances.

Researchers examine the application and usefulness of nanoparticle tracking analysis and dynamic light scattering techniques in the characterization of liposomes used as drug delivery vehicles.